Skip to main content

Table 2 TCGA Datasets Evaluated

From: Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

Symbol N Name
ACC 79 Adrenocortical carcinoma
BLCA 396 Bladder urothelial carcinoma
BRCA 1092 Breast invasive carcinoma
CESC 301 Cervical squamous cell carcinoma and endocervical adenocarcinoma
CHOL 36 Cholangiocarcinoma
COAD 280 Colon adenocarcinoma
DLBC 47 Lymphoid neoplasm diffuse large B-cell lymphoma
ESCA 183 Esophageal carcinoma
GBM 167 Glioblastoma multiforme
HNSC 516 Head and neck squamous cell carcinoma
KICH 65 Kidney chromophobe
KIRC 530 Kidney renal clear cell carcinoma
KIRP 270 Kidney renal papillary cell carcinoma
LAML 163 Acute myeloid leukemia
LGG 506 Brain lower grade glioma
LIHC 361 Liver hepatocellular carcinoma
LUAD 497 Lung adenocarcinoma
LUSC 483 Lung squamous cell carcinoma
MESO 87 Mesothelioma
OV 264 Ovarian serous cystadenocarcinoma
PAAD 179 Pancreatic adenocarcinoma
PCPG 184 Pheochromocytoma and paraganglioma
PRAD 493 Prostate adenocarcinoma
READ 95 Rectum adenocarcinoma
SARC 249 Sarcoma
SKCM 463 Skin cutaneous melanoma
STAD 409 Stomach adenocarcinoma
TGCT 139 Testicular germ cell tumors
THCA 504 Thyroid carcinoma
THYM 118 Thymoma
UCS 57 Uterine carcinosarcoma
UVM 80 Uveal melanoma